Financial News
Latest News about MRNA
Recent news which mentions MRNA
The Worst Mistake Moderna Investors Can Make in 2022
January 22, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 21, 2022
January 21, 2022
From Benzinga
From Benzinga
Why Jim Cramer Like NextEra Energy And Lincoln Electric?
January 21, 2022
From Benzinga
Novavax Stock is in a Tough Spot, but its Fortunes Could Improve
January 20, 2022
From InvestorPlace
From Motley Fool
Novavax Is Oversold, Time To Buy for Future Growth
January 20, 2022
From InvestorPlace
South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing
January 20, 2022
From MarketWatch
Novavax Is Worth 77% More Over the Next 2 Years
January 20, 2022
From InvestorPlace
Is Ocugen Stock a Buy Now?
January 20, 2022
From Motley Fool
2 REITs to Buy With Ultra-Safe Dividends
January 20, 2022
From Motley Fool
From Benzinga
From InvestorPlace
From MarketWatch
2 Top Healthcare Stocks Ready for a Bull Run
January 19, 2022
From Motley Fool
Could Novavax Go Parabolic?
January 19, 2022
From Motley Fool
5 Charts to Remember if the Stock Market Crashes in 2022
January 19, 2022
From Motley Fool
This Storage Unit Stock Has A Better 1-Year Return Than Microsoft, Apple, Starbucks And Moderna
January 18, 2022
From Benzinga
Why BioNTech, Moderna, and Novavax Stocks Are Sinking Today
January 18, 2022
From Motley Fool
Why Moderna, Pfizer, BioNTech And Novavax Shares Are Falling Today
January 18, 2022
From Benzinga
Brace for a volatile 2022, but cling to this tech stalwart when the storm comes, says investment advisor
January 18, 2022
From MarketWatch
5 Stocks Insiders Are Selling
January 18, 2022
From Benzinga
4 Shots Of Pfizer COVID-19 Vaccine Not Enough To Prevent Omicron Infection, Say Israeli Researchers
January 18, 2022
From Benzinga
Preliminary Israeli study shows fourth COVID booster doesn’t stop omicron infections
January 18, 2022
From MarketWatch
Moderna aims for COVID/flu booster in 2023, but Fauci and other virus experts warn of challenges to come this year
January 17, 2022
Tickers
MRNA
Tags
MRNA
From MarketWatch
Is Moderna Stock Too Expensive in 2022?
January 17, 2022
From Motley Fool
2 Top Biotech Stocks to Buy and Hold for 10 Years
January 17, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.